Kinetic Concepts Inc. said it’s closed the $485 million buyout of fellow privately owned wound-care company Systagenix, which it plans to unite with its LifeCell regenerative therapies unit.
Mergers & Acquisitions
Rumor: Stryker to pay $30M for ActiViews
Wound Management Tech. accepts loans, merges with Brookhaven Medical
Texas-based Wound Management Technologies entered into a merger agreement with Brookhaven Medical, a closed-doors deal tied to a series of loans proffered by Brookhaven.
Wright Medical shores up overseas extremities biz with $80M Biotech International buyout
Wright Medical (NSDQ:WMGI) said today that it agreed to pony up some $80 million for a French medical device company, Biotech International, that makes orthopedic devices for the extremities.
GE Healthcare offloads Centricity Lab unit
GE Healthcare this month handed its Centricity Laboratory Division over to Cirdan Ultra, an subsidiary of Ireland-based Cirdan Imaging Limited, which acquired the intellectual property and assets together with compatriot Kainos Software.
St. Jude Medical jumps on Nanostim buyout
St. Jude Medical (NYSE:STJ) shares gained 1.6% after the medical device company said it acquired Nanostim and its miniature leadless pacemaker following European approval of the device.
Laborie Medical buys UroMed’s pelvic rehab biz
Laborie Medical Technologies said it acquired the pelvic muscle rehabilitation business of UroMed Technology for an undisclosed amount.
Toronto-based Laborie, which is owned by private equity company Audax Group, said the UroMed business expands its offering in the pelvic muscle rehab and conservative therapy space.
Mako Surgical closes Pipeline buyout
Mako Surgical (NSDQ:MAKO) said it closed its buyout of partner Pipeline Biomedical Holdings in a cash/stock deal, ahead of its own, $1.7 billion acquisition by Stryker (NYSE:SYK).
CryoLife to cash in on Bard buyout of Medafor
CryoLife Inc. (NYSE:CRY) said it’s in line for a $15.1 million payout from the C.R. Bard (NYSE:BCR) acquisition of Minnesota-based Medafor for up to $280 million.
Biomet swings to Q1 black, announces Lanx buyout
Biomet said it’s agreed to acquire spinal implant maker Lanx Inc. for an undisclosed amount as it revealed a swing to fiscal 1st-quarter black.
The Warsaw, Ind.-based orthopedics giant said the deal will expand its spine offering with Lanx’s Timberline and Aspen spinal fusion systems.
M&A rumor mill: Ikaria looks for a $2B exit
New Jersey critical care devices maker Ikaria Inc. is rumored to be looking for an exit, hoping to claim at least $2 billion, according to unnamed sources.
Ikaria is owned by private equity and venture capital companies including Mountain Capital LLC, ARCH Venture Partners LP and Venrock Associates LP.